<DOC>
	<DOCNO>NCT02064920</DOCNO>
	<brief_summary>This study aim determine whether Cogstate test battery detect improvement cognitive function participant mild AD . The primary hypothesis standard deviation associate change baseline average One Card Learning ( OCL ) repeat measurement 12 week donepezil treatment = &lt; 0.1</brief_summary>
	<brief_title>Computerized Cognition Testing Participants With Mild Alzheimer 's Disease ( AD ) Treated With Donepezil ( MK-0000-318 )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Meets list criterion diagnosis probable AD Has clearly document history either medical record informant cognitive decline least 6 month Has reliable partner/caregiver willing provide input participate assessment Has result physical examination clinical laboratory test within normal clinically acceptable limit Can communicate trial staff acceptably , possess ability respond verbally question , follow instruction , complete questionnaire , adhere visit schedule Can read 9th grade level equivalent , acceptable history academic achievement and/or employment Has magnetic resonance imaging ( MRI ) scan rule nonAD condition contribute cognitive dysfunction Capably perform CogState screening battery Has adequate visual acuity function Females childbearing potential Has ever receive acetylcholinesterase inhibitor , memantine , symptomatic AD treatment include approve medical food Has uncontrolled , clinically significant medical condition situation within 3 month prior screen Has major surgery within 3 month prior screen Has test positive human immunodeficiency virus ( HIV ) evidence active hepatitis B infection Has history malignancy within prior 5 year Is unwilling ineligible undergo MRI scan Has history clinically important structural change screen MRI scan Has clinically important history stroke diagnosis vascular dementia Has evidence clinically relevant nonAD neurological disorder Has history head trauma , serious infectious disease affect brain within prior 35 year Has evidence clinically relevant unstable psychiatric disorder , except major depression remission Has evidence current episode major depression Has evidence Type 4 Type 5 Suicidal Ideation Has clinically significant vitamin B12 folate deficiency 6 month prior screen Is pregnant , attempt become pregnant nursing child Has use investigational drug participate clinical trial within prior 30 day Has history alcoholism drug dependency/abuse within last 5 year Has relative contraindication donepezil include sick sinus syndrome , third degree heart block , active gastrointestinal ( GI ) bleeding , ZollingerEllison syndrome , uncontrolled peptic ulcer disease , uncontrolled asthma</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>